Share

August 2022; 12 (4) Research Article

Inpatients With Dementia Referred for Palliative Care Consultation

A Multicenter Analysis

Adeline Goss, David L. O'Riordan, Steve Z. Pantilat
First published March 29, 2022, DOI: https://doi.org/10.1212/CPJ.0000000000001168
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
65

Share

Article Information

vol. 12 no. 4 288-297
DOI: 
https://doi.org/10.1212/CPJ.0000000000001168
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
2163-0402
Online ISSN: 
2163-0933
History: 
  • Received November 22, 2021
  • Accepted March 14, 2022
  • First Published March 29, 2022.

Article Versions

Copyright & Usage: 
© 2022 American Academy of Neurology

Author Disclosures

    1. Adeline Goss, MD,
    2. David L. O'Riordan, PhD and
    3. Steve Z. Pantilat, MD
  1. Adeline Goss, MD,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. (1) Host and executive producer of the American Neurological Association's podcast, ANA Investigates. A new episode of the podcast is released each month, and I receive $750 compensation for producing each of these episodes.

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. David L. O'Riordan, PhD and
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Steve Z. Pantilat, MD
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. Oakstone Publishing- honoararium; Northwest Kidney Centers- honorarium

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. Life After the Diagnosis: Expert Advice on Living Well with Serious Illness for Patients and Caregivers; DaCapo Lifelong Books, Hachette, 2017 Hospital Based Palliative Medicine; Wiley; 2015 Care at the Close of Life; McGraw Hill, 2011 Current Medical Diagnosis and Treatment, 2022; McGraw Hill, 2022

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. Stupski Foundation, non-profit entity

    Speakers' Bureaus:

    1. Leigh Bureau, commercial entity

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Archstone Foundation, PI, 10/18-9/21 Stupski Foundation, PI 6/20-6/23 Gordon and Betty Moore Foundation, co investigator, 7/18-6/21 Hellman Foundation, PI 9/18-8/24 UniHealth Foundation, PI 1/19-12/21

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. Division of Neurology (AG), Highland Hospital, Oakland, CA; Division of Palliative Medicine (DLO, SZP), University of California San Francisco.
  1. Correspondence
    Dr. Pantilat steve.pantilat{at}ucsf.edu
View Full Text

Article usage

Article usage: March 2022 to April 2023

AbstractFullPdfSource
Mar 202223708Highwire
Apr 202213207Highwire
May 20223203Highwire
Jun 20224502Highwire
Jul 20222702Highwire
Aug 20224042417Highwire
Sep 2022195108Highwire
Oct 20227645Highwire
Nov 202216572Highwire
Dec 20226622Highwire
Jan 20236912Highwire
Feb 20234934Highwire
Mar 20236212Highwire
Apr 20234401Highwire

Cited By...

The Nerve!: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
Advertisement

Podcast

Download MP3

Related Articles

  • No related articles found.

Topics Discussed

Alert Me